Entecavir and Oxycontin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Entecavir (entecavir) and Oxycontin (oxycodone hydrochloride). Common drug interactions include cancer pain among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Entecavir and Oxycontin. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Entecavir?

Entecavir has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 7,354 Entecavir users. Check the latest studies of Entecavir.

What is Oxycontin?

Oxycontin has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 212,533 Oxycontin users. Check the latest studies of Oxycontin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

17 people who take Entecavir and Oxycontin together, and have interactions are studied.

Entecavir and Oxycontin drug interactions.

What are the common drug interactions of Entecavir and Oxycontin, by gender? *:

female:

Cancer pain
Drug hypersensitivity
Gastrointestinal perforation (hole in the digestive tract)
Impaired healing
Fatigue (feeling of tiredness)
Hyperkalaemia (damage to or disease of the kidney)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Dizziness
Nausea (feeling of having an urge to vomit)

male:

Diarrhoea
Spinal compression fracture (fracture due to spinal compression on bone)
Gait disturbance
Multiple fractures
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Quality of life decreased
Dehydration (dryness resulting from the removal of water)
Foot fracture
Hypokalaemia (low potassium)

What are the common drug interactions of Entecavir and Oxycontin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Cancer pain
Drug hypersensitivity
Gastrointestinal perforation (hole in the digestive tract)
Impaired healing

50-59:

Spinal compression fracture (fracture due to spinal compression on bone)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Arthralgia (joint pain)
Bone density decreased
Cervical spinal stenosis (narrowing of the spinal canal in the neck)
Decreased activity
Depression
Emotional distress
Gait disturbance

60+:

Diarrhoea
Fatigue (feeling of tiredness)
Pyrexia (fever)
Dehydration (dryness resulting from the removal of water)
Hypokalaemia (low potassium)
Hyperkalaemia (damage to or disease of the kidney)
Nausea (feeling of having an urge to vomit)
Neutropenia (an abnormally low number of neutrophils)
Swelling
Hypertension (high blood pressure)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 29.41%
High Blood Pressure: 5 people, 29.41%
Insomnia (sleeplessness): 5 people, 29.41%
Nausea (feeling of having an urge to vomit): 4 people, 23.53%
Indigestion: 4 people, 23.53%
Hepatocellular Carcinoma (liver cancer): 4 people, 23.53%
Prostatomegaly (enlargement of the prostate): 3 people, 17.65%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 17.65%
Fungal Infection: 3 people, 17.65%
Cancer Pain: 3 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take Entecavir and Oxycontin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously